nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—Epirubicin—stomach cancer	0.414	0.92	CbGbCtD
Orlistat—CYP3A4—Irinotecan—stomach cancer	0.0158	0.0351	CbGbCtD
Orlistat—LIPF—digestive system—stomach cancer	0.0122	0.118	CbGeAlD
Orlistat—CYP3A4—Docetaxel—stomach cancer	0.0116	0.0257	CbGbCtD
Orlistat—CYP3A4—Doxorubicin—stomach cancer	0.00863	0.0192	CbGbCtD
Orlistat—PLA2G7—hematopoietic system—stomach cancer	0.00708	0.0683	CbGeAlD
Orlistat—PNLIP—hematopoietic system—stomach cancer	0.00623	0.06	CbGeAlD
Orlistat—ABHD16A—pancreas—stomach cancer	0.00541	0.0522	CbGeAlD
Orlistat—PNLIP—pancreas—stomach cancer	0.00507	0.0489	CbGeAlD
Orlistat—PLA2G7—lymphoid tissue—stomach cancer	0.00499	0.0481	CbGeAlD
Orlistat—DAGLB—liver—stomach cancer	0.00454	0.0438	CbGeAlD
Orlistat—PLA2G7—bone marrow—stomach cancer	0.00454	0.0438	CbGeAlD
Orlistat—PLA2G4A—Raltitrexed—Methotrexate—stomach cancer	0.00439	1	CbGdCrCtD
Orlistat—PNLIP—digestive system—stomach cancer	0.00433	0.0418	CbGeAlD
Orlistat—ABHD16A—bone marrow—stomach cancer	0.00426	0.0411	CbGeAlD
Orlistat—PLA2G7—endocrine gland—stomach cancer	0.00407	0.0392	CbGeAlD
Orlistat—PLA2G7—liver—stomach cancer	0.00367	0.0354	CbGeAlD
Orlistat—PNLIP—endocrine gland—stomach cancer	0.00358	0.0345	CbGeAlD
Orlistat—DAGLB—lymph node—stomach cancer	0.00348	0.0336	CbGeAlD
Orlistat—ABHD12—liver—stomach cancer	0.00323	0.0311	CbGeAlD
Orlistat—PNLIP—liver—stomach cancer	0.00323	0.0311	CbGeAlD
Orlistat—PLA2G7—lymph node—stomach cancer	0.00281	0.0271	CbGeAlD
Orlistat—FASN—liver—stomach cancer	0.00271	0.0261	CbGeAlD
Orlistat—ABHD16A—lymph node—stomach cancer	0.00264	0.0255	CbGeAlD
Orlistat—PLA2G4A—hematopoietic system—stomach cancer	0.00251	0.0242	CbGeAlD
Orlistat—ABHD12—lymph node—stomach cancer	0.00247	0.0239	CbGeAlD
Orlistat—PLA2G4A—smooth muscle tissue—stomach cancer	0.00221	0.0213	CbGeAlD
Orlistat—FASN—lymph node—stomach cancer	0.00208	0.02	CbGeAlD
Orlistat—PLA2G4A—bone marrow—stomach cancer	0.00161	0.0155	CbGeAlD
Orlistat—PLA2G4A—endocrine gland—stomach cancer	0.00144	0.0139	CbGeAlD
Orlistat—PLA2G4A—lymph node—stomach cancer	0.000998	0.00962	CbGeAlD
Orlistat—CYP3A4—hematopoietic system—stomach cancer	0.000829	0.00799	CbGeAlD
Orlistat—CYP3A4—digestive system—stomach cancer	0.000576	0.00556	CbGeAlD
Orlistat—CYP3A4—endocrine gland—stomach cancer	0.000476	0.00459	CbGeAlD
Orlistat—CYP3A4—liver—stomach cancer	0.000429	0.00414	CbGeAlD
Orlistat—Hepatitis—Methotrexate—stomach cancer	0.000207	0.00101	CcSEcCtD
Orlistat—Chest pain—Capecitabine—stomach cancer	0.000206	0.001	CcSEcCtD
Orlistat—Myalgia—Capecitabine—stomach cancer	0.000206	0.001	CcSEcCtD
Orlistat—Pharyngitis—Methotrexate—stomach cancer	0.000206	0.001	CcSEcCtD
Orlistat—Anxiety—Capecitabine—stomach cancer	0.000206	0.001	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000205	0.000997	CcSEcCtD
Orlistat—Urinary tract disorder—Methotrexate—stomach cancer	0.000205	0.000996	CcSEcCtD
Orlistat—Hepatobiliary disease—Epirubicin—stomach cancer	0.000204	0.000994	CcSEcCtD
Orlistat—Anaphylactic shock—Docetaxel—stomach cancer	0.000204	0.000994	CcSEcCtD
Orlistat—Oedema—Docetaxel—stomach cancer	0.000204	0.000994	CcSEcCtD
Orlistat—Discomfort—Capecitabine—stomach cancer	0.000204	0.000992	CcSEcCtD
Orlistat—Urethral disorder—Methotrexate—stomach cancer	0.000203	0.000988	CcSEcCtD
Orlistat—Infection—Docetaxel—stomach cancer	0.000203	0.000987	CcSEcCtD
Orlistat—Sinusitis—Epirubicin—stomach cancer	0.000203	0.000986	CcSEcCtD
Orlistat—Diarrhoea—Irinotecan—stomach cancer	0.000202	0.000984	CcSEcCtD
Orlistat—Dry mouth—Capecitabine—stomach cancer	0.000202	0.000982	CcSEcCtD
Orlistat—Nervous system disorder—Docetaxel—stomach cancer	0.0002	0.000975	CcSEcCtD
Orlistat—Pruritus—Fluorouracil—stomach cancer	0.0002	0.000974	CcSEcCtD
Orlistat—Infestation—Doxorubicin—stomach cancer	0.0002	0.000972	CcSEcCtD
Orlistat—Infestation NOS—Doxorubicin—stomach cancer	0.0002	0.000972	CcSEcCtD
Orlistat—Skin disorder—Docetaxel—stomach cancer	0.000198	0.000965	CcSEcCtD
Orlistat—Oedema—Capecitabine—stomach cancer	0.000198	0.000962	CcSEcCtD
Orlistat—Renal failure—Doxorubicin—stomach cancer	0.000197	0.000956	CcSEcCtD
Orlistat—Infection—Capecitabine—stomach cancer	0.000197	0.000956	CcSEcCtD
Orlistat—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000196	0.000953	CcSEcCtD
Orlistat—Dizziness—Irinotecan—stomach cancer	0.000195	0.000951	CcSEcCtD
Orlistat—Haemoglobin—Epirubicin—stomach cancer	0.000195	0.000948	CcSEcCtD
Orlistat—Urinary tract infection—Doxorubicin—stomach cancer	0.000194	0.000945	CcSEcCtD
Orlistat—Nervous system disorder—Capecitabine—stomach cancer	0.000194	0.000944	CcSEcCtD
Orlistat—Hepatitis—Epirubicin—stomach cancer	0.000194	0.000944	CcSEcCtD
Orlistat—Haemorrhage—Epirubicin—stomach cancer	0.000194	0.000944	CcSEcCtD
Orlistat—Diarrhoea—Fluorouracil—stomach cancer	0.000194	0.000942	CcSEcCtD
Orlistat—Pharyngitis—Epirubicin—stomach cancer	0.000192	0.000936	CcSEcCtD
Orlistat—Skin disorder—Capecitabine—stomach cancer	0.000192	0.000935	CcSEcCtD
Orlistat—Urinary tract disorder—Epirubicin—stomach cancer	0.000192	0.000932	CcSEcCtD
Orlistat—Hyperhidrosis—Capecitabine—stomach cancer	0.000191	0.00093	CcSEcCtD
Orlistat—Oedema peripheral—Epirubicin—stomach cancer	0.000191	0.000929	CcSEcCtD
Orlistat—Urethral disorder—Epirubicin—stomach cancer	0.00019	0.000925	CcSEcCtD
Orlistat—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000189	0.00092	CcSEcCtD
Orlistat—Vomiting—Irinotecan—stomach cancer	0.000188	0.000914	CcSEcCtD
Orlistat—Sinusitis—Doxorubicin—stomach cancer	0.000188	0.000912	CcSEcCtD
Orlistat—Immune system disorder—Methotrexate—stomach cancer	0.000187	0.000911	CcSEcCtD
Orlistat—Dizziness—Fluorouracil—stomach cancer	0.000187	0.000911	CcSEcCtD
Orlistat—Mediastinal disorder—Methotrexate—stomach cancer	0.000187	0.000909	CcSEcCtD
Orlistat—Rash—Irinotecan—stomach cancer	0.000186	0.000906	CcSEcCtD
Orlistat—Dermatitis—Irinotecan—stomach cancer	0.000186	0.000906	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000186	0.000905	CcSEcCtD
Orlistat—Headache—Irinotecan—stomach cancer	0.000185	0.000901	CcSEcCtD
Orlistat—Insomnia—Docetaxel—stomach cancer	0.000185	0.000899	CcSEcCtD
Orlistat—Paraesthesia—Docetaxel—stomach cancer	0.000183	0.000892	CcSEcCtD
Orlistat—Alopecia—Methotrexate—stomach cancer	0.000183	0.000891	CcSEcCtD
Orlistat—Mental disorder—Methotrexate—stomach cancer	0.000182	0.000883	CcSEcCtD
Orlistat—Malnutrition—Methotrexate—stomach cancer	0.00018	0.000878	CcSEcCtD
Orlistat—Haemoglobin—Doxorubicin—stomach cancer	0.00018	0.000877	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00018	0.000877	CcSEcCtD
Orlistat—Vomiting—Fluorouracil—stomach cancer	0.00018	0.000875	CcSEcCtD
Orlistat—Dyspepsia—Docetaxel—stomach cancer	0.00018	0.000875	CcSEcCtD
Orlistat—Hepatitis—Doxorubicin—stomach cancer	0.000179	0.000873	CcSEcCtD
Orlistat—Haemorrhage—Doxorubicin—stomach cancer	0.000179	0.000873	CcSEcCtD
Orlistat—Insomnia—Capecitabine—stomach cancer	0.000179	0.00087	CcSEcCtD
Orlistat—Rash—Fluorouracil—stomach cancer	0.000178	0.000868	CcSEcCtD
Orlistat—Dermatitis—Fluorouracil—stomach cancer	0.000178	0.000867	CcSEcCtD
Orlistat—Pharyngitis—Doxorubicin—stomach cancer	0.000178	0.000866	CcSEcCtD
Orlistat—Paraesthesia—Capecitabine—stomach cancer	0.000178	0.000864	CcSEcCtD
Orlistat—Decreased appetite—Docetaxel—stomach cancer	0.000178	0.000864	CcSEcCtD
Orlistat—Headache—Fluorouracil—stomach cancer	0.000177	0.000863	CcSEcCtD
Orlistat—Urinary tract disorder—Doxorubicin—stomach cancer	0.000177	0.000862	CcSEcCtD
Orlistat—Oedema peripheral—Doxorubicin—stomach cancer	0.000177	0.00086	CcSEcCtD
Orlistat—Dysgeusia—Methotrexate—stomach cancer	0.000177	0.000859	CcSEcCtD
Orlistat—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000176	0.000858	CcSEcCtD
Orlistat—Fatigue—Docetaxel—stomach cancer	0.000176	0.000857	CcSEcCtD
Orlistat—Urethral disorder—Doxorubicin—stomach cancer	0.000176	0.000856	CcSEcCtD
Orlistat—Nausea—Irinotecan—stomach cancer	0.000176	0.000854	CcSEcCtD
Orlistat—Immune system disorder—Epirubicin—stomach cancer	0.000175	0.000852	CcSEcCtD
Orlistat—Mediastinal disorder—Epirubicin—stomach cancer	0.000175	0.00085	CcSEcCtD
Orlistat—Pain—Docetaxel—stomach cancer	0.000175	0.00085	CcSEcCtD
Orlistat—Back pain—Methotrexate—stomach cancer	0.000175	0.000849	CcSEcCtD
Orlistat—Dyspepsia—Capecitabine—stomach cancer	0.000174	0.000847	CcSEcCtD
Orlistat—Decreased appetite—Capecitabine—stomach cancer	0.000172	0.000836	CcSEcCtD
Orlistat—Alopecia—Epirubicin—stomach cancer	0.000171	0.000834	CcSEcCtD
Orlistat—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000171	0.000831	CcSEcCtD
Orlistat—Fatigue—Capecitabine—stomach cancer	0.000171	0.00083	CcSEcCtD
Orlistat—Vision blurred—Methotrexate—stomach cancer	0.00017	0.000827	CcSEcCtD
Orlistat—Mental disorder—Epirubicin—stomach cancer	0.00017	0.000827	CcSEcCtD
Orlistat—Pain—Capecitabine—stomach cancer	0.000169	0.000823	CcSEcCtD
Orlistat—Malnutrition—Epirubicin—stomach cancer	0.000169	0.000821	CcSEcCtD
Orlistat—Feeling abnormal—Docetaxel—stomach cancer	0.000168	0.000819	CcSEcCtD
Orlistat—Nausea—Fluorouracil—stomach cancer	0.000168	0.000818	CcSEcCtD
Orlistat—Ill-defined disorder—Methotrexate—stomach cancer	0.000167	0.000814	CcSEcCtD
Orlistat—Gastrointestinal pain—Docetaxel—stomach cancer	0.000167	0.000813	CcSEcCtD
Orlistat—Flatulence—Epirubicin—stomach cancer	0.000166	0.000809	CcSEcCtD
Orlistat—Dysgeusia—Epirubicin—stomach cancer	0.000165	0.000804	CcSEcCtD
Orlistat—Back pain—Epirubicin—stomach cancer	0.000163	0.000794	CcSEcCtD
Orlistat—Feeling abnormal—Capecitabine—stomach cancer	0.000163	0.000793	CcSEcCtD
Orlistat—Malaise—Methotrexate—stomach cancer	0.000163	0.000791	CcSEcCtD
Orlistat—Muscle spasms—Epirubicin—stomach cancer	0.000162	0.00079	CcSEcCtD
Orlistat—Immune system disorder—Doxorubicin—stomach cancer	0.000162	0.000789	CcSEcCtD
Orlistat—Vertigo—Methotrexate—stomach cancer	0.000162	0.000789	CcSEcCtD
Orlistat—Gastrointestinal pain—Capecitabine—stomach cancer	0.000162	0.000787	CcSEcCtD
Orlistat—Mediastinal disorder—Doxorubicin—stomach cancer	0.000162	0.000787	CcSEcCtD
Orlistat—Abdominal pain—Docetaxel—stomach cancer	0.000161	0.000786	CcSEcCtD
Orlistat—Body temperature increased—Docetaxel—stomach cancer	0.000161	0.000786	CcSEcCtD
Orlistat—Vision blurred—Epirubicin—stomach cancer	0.000159	0.000774	CcSEcCtD
Orlistat—Alopecia—Doxorubicin—stomach cancer	0.000159	0.000771	CcSEcCtD
Orlistat—Cough—Methotrexate—stomach cancer	0.000157	0.000766	CcSEcCtD
Orlistat—Mental disorder—Doxorubicin—stomach cancer	0.000157	0.000765	CcSEcCtD
Orlistat—Urticaria—Capecitabine—stomach cancer	0.000157	0.000764	CcSEcCtD
Orlistat—Ill-defined disorder—Epirubicin—stomach cancer	0.000157	0.000762	CcSEcCtD
Orlistat—Abdominal pain—Capecitabine—stomach cancer	0.000156	0.000761	CcSEcCtD
Orlistat—Body temperature increased—Capecitabine—stomach cancer	0.000156	0.000761	CcSEcCtD
Orlistat—Convulsion—Methotrexate—stomach cancer	0.000156	0.00076	CcSEcCtD
Orlistat—Malnutrition—Doxorubicin—stomach cancer	0.000156	0.00076	CcSEcCtD
Orlistat—Flatulence—Doxorubicin—stomach cancer	0.000154	0.000749	CcSEcCtD
Orlistat—Chest pain—Methotrexate—stomach cancer	0.000154	0.000747	CcSEcCtD
Orlistat—Myalgia—Methotrexate—stomach cancer	0.000154	0.000747	CcSEcCtD
Orlistat—Dysgeusia—Doxorubicin—stomach cancer	0.000153	0.000744	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000153	0.000742	CcSEcCtD
Orlistat—Malaise—Epirubicin—stomach cancer	0.000152	0.000741	CcSEcCtD
Orlistat—Discomfort—Methotrexate—stomach cancer	0.000152	0.000738	CcSEcCtD
Orlistat—Vertigo—Epirubicin—stomach cancer	0.000152	0.000738	CcSEcCtD
Orlistat—Back pain—Doxorubicin—stomach cancer	0.000151	0.000735	CcSEcCtD
Orlistat—Hypersensitivity—Docetaxel—stomach cancer	0.000151	0.000732	CcSEcCtD
Orlistat—Muscle spasms—Doxorubicin—stomach cancer	0.00015	0.000731	CcSEcCtD
Orlistat—Palpitations—Epirubicin—stomach cancer	0.000149	0.000726	CcSEcCtD
Orlistat—Cough—Epirubicin—stomach cancer	0.000147	0.000717	CcSEcCtD
Orlistat—Anaphylactic shock—Methotrexate—stomach cancer	0.000147	0.000716	CcSEcCtD
Orlistat—Vision blurred—Doxorubicin—stomach cancer	0.000147	0.000716	CcSEcCtD
Orlistat—Asthenia—Docetaxel—stomach cancer	0.000147	0.000713	CcSEcCtD
Orlistat—Convulsion—Epirubicin—stomach cancer	0.000146	0.000712	CcSEcCtD
Orlistat—Infection—Methotrexate—stomach cancer	0.000146	0.000712	CcSEcCtD
Orlistat—Hypersensitivity—Capecitabine—stomach cancer	0.000146	0.000709	CcSEcCtD
Orlistat—Ill-defined disorder—Doxorubicin—stomach cancer	0.000145	0.000705	CcSEcCtD
Orlistat—Pruritus—Docetaxel—stomach cancer	0.000145	0.000703	CcSEcCtD
Orlistat—Nervous system disorder—Methotrexate—stomach cancer	0.000144	0.000702	CcSEcCtD
Orlistat—Chest pain—Epirubicin—stomach cancer	0.000144	0.000699	CcSEcCtD
Orlistat—Myalgia—Epirubicin—stomach cancer	0.000144	0.000699	CcSEcCtD
Orlistat—Anxiety—Epirubicin—stomach cancer	0.000143	0.000697	CcSEcCtD
Orlistat—Skin disorder—Methotrexate—stomach cancer	0.000143	0.000696	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000143	0.000694	CcSEcCtD
Orlistat—Hyperhidrosis—Methotrexate—stomach cancer	0.000142	0.000692	CcSEcCtD
Orlistat—Discomfort—Epirubicin—stomach cancer	0.000142	0.000691	CcSEcCtD
Orlistat—Asthenia—Capecitabine—stomach cancer	0.000142	0.00069	CcSEcCtD
Orlistat—Malaise—Doxorubicin—stomach cancer	0.000141	0.000685	CcSEcCtD
Orlistat—Dry mouth—Epirubicin—stomach cancer	0.000141	0.000684	CcSEcCtD
Orlistat—Vertigo—Doxorubicin—stomach cancer	0.00014	0.000683	CcSEcCtD
Orlistat—Pruritus—Capecitabine—stomach cancer	0.00014	0.000681	CcSEcCtD
Orlistat—Diarrhoea—Docetaxel—stomach cancer	0.00014	0.00068	CcSEcCtD
Orlistat—Palpitations—Doxorubicin—stomach cancer	0.000138	0.000672	CcSEcCtD
Orlistat—Anaphylactic shock—Epirubicin—stomach cancer	0.000138	0.00067	CcSEcCtD
Orlistat—Oedema—Epirubicin—stomach cancer	0.000138	0.00067	CcSEcCtD
Orlistat—Infection—Epirubicin—stomach cancer	0.000137	0.000666	CcSEcCtD
Orlistat—Cough—Doxorubicin—stomach cancer	0.000136	0.000663	CcSEcCtD
Orlistat—Convulsion—Doxorubicin—stomach cancer	0.000135	0.000658	CcSEcCtD
Orlistat—Diarrhoea—Capecitabine—stomach cancer	0.000135	0.000658	CcSEcCtD
Orlistat—Nervous system disorder—Epirubicin—stomach cancer	0.000135	0.000657	CcSEcCtD
Orlistat—Dizziness—Docetaxel—stomach cancer	0.000135	0.000657	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000134	0.000653	CcSEcCtD
Orlistat—Skin disorder—Epirubicin—stomach cancer	0.000134	0.000651	CcSEcCtD
Orlistat—Hyperhidrosis—Epirubicin—stomach cancer	0.000133	0.000648	CcSEcCtD
Orlistat—Insomnia—Methotrexate—stomach cancer	0.000133	0.000648	CcSEcCtD
Orlistat—Myalgia—Doxorubicin—stomach cancer	0.000133	0.000647	CcSEcCtD
Orlistat—Chest pain—Doxorubicin—stomach cancer	0.000133	0.000647	CcSEcCtD
Orlistat—Anxiety—Doxorubicin—stomach cancer	0.000133	0.000645	CcSEcCtD
Orlistat—Paraesthesia—Methotrexate—stomach cancer	0.000132	0.000643	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000132	0.000643	CcSEcCtD
Orlistat—Discomfort—Doxorubicin—stomach cancer	0.000131	0.000639	CcSEcCtD
Orlistat—Dizziness—Capecitabine—stomach cancer	0.000131	0.000636	CcSEcCtD
Orlistat—Dry mouth—Doxorubicin—stomach cancer	0.00013	0.000633	CcSEcCtD
Orlistat—Vomiting—Docetaxel—stomach cancer	0.00013	0.000632	CcSEcCtD
Orlistat—Dyspepsia—Methotrexate—stomach cancer	0.00013	0.000631	CcSEcCtD
Orlistat—Rash—Docetaxel—stomach cancer	0.000129	0.000627	CcSEcCtD
Orlistat—Dermatitis—Docetaxel—stomach cancer	0.000129	0.000626	CcSEcCtD
Orlistat—Decreased appetite—Methotrexate—stomach cancer	0.000128	0.000623	CcSEcCtD
Orlistat—Headache—Docetaxel—stomach cancer	0.000128	0.000623	CcSEcCtD
Orlistat—Anaphylactic shock—Doxorubicin—stomach cancer	0.000127	0.00062	CcSEcCtD
Orlistat—Oedema—Doxorubicin—stomach cancer	0.000127	0.00062	CcSEcCtD
Orlistat—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000127	0.000618	CcSEcCtD
Orlistat—Fatigue—Methotrexate—stomach cancer	0.000127	0.000618	CcSEcCtD
Orlistat—Infection—Doxorubicin—stomach cancer	0.000127	0.000616	CcSEcCtD
Orlistat—Pain—Methotrexate—stomach cancer	0.000126	0.000613	CcSEcCtD
Orlistat—Vomiting—Capecitabine—stomach cancer	0.000126	0.000612	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000126	0.000611	CcSEcCtD
Orlistat—Nervous system disorder—Doxorubicin—stomach cancer	0.000125	0.000608	CcSEcCtD
Orlistat—Rash—Capecitabine—stomach cancer	0.000125	0.000607	CcSEcCtD
Orlistat—Insomnia—Epirubicin—stomach cancer	0.000125	0.000606	CcSEcCtD
Orlistat—Dermatitis—Capecitabine—stomach cancer	0.000125	0.000606	CcSEcCtD
Orlistat—Headache—Capecitabine—stomach cancer	0.000124	0.000603	CcSEcCtD
Orlistat—Skin disorder—Doxorubicin—stomach cancer	0.000124	0.000602	CcSEcCtD
Orlistat—Paraesthesia—Epirubicin—stomach cancer	0.000124	0.000602	CcSEcCtD
Orlistat—Hyperhidrosis—Doxorubicin—stomach cancer	0.000123	0.0006	CcSEcCtD
Orlistat—Nausea—Docetaxel—stomach cancer	0.000121	0.00059	CcSEcCtD
Orlistat—Feeling abnormal—Methotrexate—stomach cancer	0.000121	0.00059	CcSEcCtD
Orlistat—Dyspepsia—Epirubicin—stomach cancer	0.000121	0.00059	CcSEcCtD
Orlistat—Gastrointestinal pain—Methotrexate—stomach cancer	0.00012	0.000586	CcSEcCtD
Orlistat—Decreased appetite—Epirubicin—stomach cancer	0.00012	0.000583	CcSEcCtD
Orlistat—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000119	0.000579	CcSEcCtD
Orlistat—Fatigue—Epirubicin—stomach cancer	0.000119	0.000578	CcSEcCtD
Orlistat—Pain—Epirubicin—stomach cancer	0.000118	0.000573	CcSEcCtD
Orlistat—Nausea—Capecitabine—stomach cancer	0.000117	0.000572	CcSEcCtD
Orlistat—Urticaria—Methotrexate—stomach cancer	0.000117	0.000569	CcSEcCtD
Orlistat—Body temperature increased—Methotrexate—stomach cancer	0.000116	0.000566	CcSEcCtD
Orlistat—Abdominal pain—Methotrexate—stomach cancer	0.000116	0.000566	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000116	0.000565	CcSEcCtD
Orlistat—Insomnia—Doxorubicin—stomach cancer	0.000115	0.000561	CcSEcCtD
Orlistat—Paraesthesia—Doxorubicin—stomach cancer	0.000114	0.000557	CcSEcCtD
Orlistat—Feeling abnormal—Epirubicin—stomach cancer	0.000114	0.000552	CcSEcCtD
Orlistat—Gastrointestinal pain—Epirubicin—stomach cancer	0.000113	0.000548	CcSEcCtD
Orlistat—Dyspepsia—Doxorubicin—stomach cancer	0.000112	0.000546	CcSEcCtD
Orlistat—Decreased appetite—Doxorubicin—stomach cancer	0.000111	0.000539	CcSEcCtD
Orlistat—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00011	0.000535	CcSEcCtD
Orlistat—Fatigue—Doxorubicin—stomach cancer	0.00011	0.000535	CcSEcCtD
Orlistat—Urticaria—Epirubicin—stomach cancer	0.000109	0.000533	CcSEcCtD
Orlistat—Pain—Doxorubicin—stomach cancer	0.000109	0.00053	CcSEcCtD
Orlistat—Abdominal pain—Epirubicin—stomach cancer	0.000109	0.00053	CcSEcCtD
Orlistat—Body temperature increased—Epirubicin—stomach cancer	0.000109	0.00053	CcSEcCtD
Orlistat—Hypersensitivity—Methotrexate—stomach cancer	0.000108	0.000528	CcSEcCtD
Orlistat—Asthenia—Methotrexate—stomach cancer	0.000106	0.000514	CcSEcCtD
Orlistat—Feeling abnormal—Doxorubicin—stomach cancer	0.000105	0.000511	CcSEcCtD
Orlistat—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000104	0.000507	CcSEcCtD
Orlistat—Pruritus—Methotrexate—stomach cancer	0.000104	0.000507	CcSEcCtD
Orlistat—Hypersensitivity—Epirubicin—stomach cancer	0.000102	0.000494	CcSEcCtD
Orlistat—Urticaria—Doxorubicin—stomach cancer	0.000101	0.000493	CcSEcCtD
Orlistat—Body temperature increased—Doxorubicin—stomach cancer	0.000101	0.00049	CcSEcCtD
Orlistat—Abdominal pain—Doxorubicin—stomach cancer	0.000101	0.00049	CcSEcCtD
Orlistat—Diarrhoea—Methotrexate—stomach cancer	0.000101	0.00049	CcSEcCtD
Orlistat—Asthenia—Epirubicin—stomach cancer	9.89e-05	0.000481	CcSEcCtD
Orlistat—Pruritus—Epirubicin—stomach cancer	9.75e-05	0.000474	CcSEcCtD
Orlistat—Dizziness—Methotrexate—stomach cancer	9.74e-05	0.000474	CcSEcCtD
Orlistat—Diarrhoea—Epirubicin—stomach cancer	9.43e-05	0.000459	CcSEcCtD
Orlistat—Hypersensitivity—Doxorubicin—stomach cancer	9.39e-05	0.000457	CcSEcCtD
Orlistat—Vomiting—Methotrexate—stomach cancer	9.36e-05	0.000455	CcSEcCtD
Orlistat—Rash—Methotrexate—stomach cancer	9.28e-05	0.000452	CcSEcCtD
Orlistat—Dermatitis—Methotrexate—stomach cancer	9.28e-05	0.000451	CcSEcCtD
Orlistat—Headache—Methotrexate—stomach cancer	9.22e-05	0.000449	CcSEcCtD
Orlistat—Asthenia—Doxorubicin—stomach cancer	9.15e-05	0.000445	CcSEcCtD
Orlistat—Dizziness—Epirubicin—stomach cancer	9.11e-05	0.000443	CcSEcCtD
Orlistat—Pruritus—Doxorubicin—stomach cancer	9.02e-05	0.000439	CcSEcCtD
Orlistat—Vomiting—Epirubicin—stomach cancer	8.76e-05	0.000426	CcSEcCtD
Orlistat—Nausea—Methotrexate—stomach cancer	8.75e-05	0.000425	CcSEcCtD
Orlistat—Diarrhoea—Doxorubicin—stomach cancer	8.72e-05	0.000424	CcSEcCtD
Orlistat—Rash—Epirubicin—stomach cancer	8.69e-05	0.000423	CcSEcCtD
Orlistat—Dermatitis—Epirubicin—stomach cancer	8.68e-05	0.000422	CcSEcCtD
Orlistat—Headache—Epirubicin—stomach cancer	8.63e-05	0.00042	CcSEcCtD
Orlistat—Dizziness—Doxorubicin—stomach cancer	8.43e-05	0.00041	CcSEcCtD
Orlistat—Nausea—Epirubicin—stomach cancer	8.18e-05	0.000398	CcSEcCtD
Orlistat—Vomiting—Doxorubicin—stomach cancer	8.11e-05	0.000394	CcSEcCtD
Orlistat—Rash—Doxorubicin—stomach cancer	8.04e-05	0.000391	CcSEcCtD
Orlistat—Dermatitis—Doxorubicin—stomach cancer	8.03e-05	0.000391	CcSEcCtD
Orlistat—Headache—Doxorubicin—stomach cancer	7.99e-05	0.000389	CcSEcCtD
Orlistat—Nausea—Doxorubicin—stomach cancer	7.57e-05	0.000368	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.24e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—stomach cancer	3.23e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—stomach cancer	3.23e-05	0.000137	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.22e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HRAS—stomach cancer	3.21e-05	0.000136	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HRAS—stomach cancer	3.21e-05	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALOX5—stomach cancer	3.21e-05	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.21e-05	0.000136	CbGpPWpGaD
Orlistat—FASN—Disease—SERPINE1—stomach cancer	3.19e-05	0.000135	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SERPINE1—stomach cancer	3.16e-05	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DPYD—stomach cancer	3.15e-05	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FST—stomach cancer	3.15e-05	0.000134	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1B—stomach cancer	3.15e-05	0.000134	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1B—stomach cancer	3.15e-05	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HBEGF—stomach cancer	3.08e-05	0.000131	CbGpPWpGaD
Orlistat—FASN—Disease—RHOA—stomach cancer	3.08e-05	0.00013	CbGpPWpGaD
Orlistat—PNLIP—Disease—STAT3—stomach cancer	3.07e-05	0.00013	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—stomach cancer	3.07e-05	0.00013	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—stomach cancer	3.07e-05	0.00013	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RHOA—stomach cancer	3.05e-05	0.000129	CbGpPWpGaD
Orlistat—FASN—Disease—NOS3—stomach cancer	3.05e-05	0.000129	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RGS2—stomach cancer	3.04e-05	0.000129	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GAST—stomach cancer	3.04e-05	0.000129	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOS3—stomach cancer	3.02e-05	0.000128	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCND1—stomach cancer	3.01e-05	0.000127	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCND1—stomach cancer	3.01e-05	0.000127	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—JUN—stomach cancer	3e-05	0.000127	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—JUN—stomach cancer	3e-05	0.000127	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—stomach cancer	2.97e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	2.95e-05	0.000125	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAPK3—stomach cancer	2.94e-05	0.000124	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—stomach cancer	2.92e-05	0.000124	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—stomach cancer	2.92e-05	0.000124	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1A—stomach cancer	2.91e-05	0.000123	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1A—stomach cancer	2.91e-05	0.000123	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGG—stomach cancer	2.88e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.86e-05	0.000121	CbGpPWpGaD
Orlistat—PNLIP—Disease—MYC—stomach cancer	2.85e-05	0.000121	CbGpPWpGaD
Orlistat—FASN—Disease—ERBB2—stomach cancer	2.85e-05	0.000121	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADRB2—stomach cancer	2.85e-05	0.000121	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAPK8—stomach cancer	2.84e-05	0.00012	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAPK8—stomach cancer	2.84e-05	0.00012	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINE1—stomach cancer	2.83e-05	0.00012	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ALB—stomach cancer	2.82e-05	0.00012	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ERBB2—stomach cancer	2.82e-05	0.000119	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAPK1—stomach cancer	2.79e-05	0.000118	CbGpPWpGaD
Orlistat—PNLIP—Disease—EGFR—stomach cancer	2.79e-05	0.000118	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PPP2R1A—stomach cancer	2.79e-05	0.000118	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTT1—stomach cancer	2.79e-05	0.000118	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—stomach cancer	2.79e-05	0.000118	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRKAA1—stomach cancer	2.78e-05	0.000118	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP2A6—stomach cancer	2.76e-05	0.000117	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—RHOA—stomach cancer	2.73e-05	0.000116	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS3—stomach cancer	2.7e-05	0.000114	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKR1C3—stomach cancer	2.68e-05	0.000114	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RBP4—stomach cancer	2.68e-05	0.000114	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—stomach cancer	2.68e-05	0.000113	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALB—stomach cancer	2.67e-05	0.000113	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTP1—stomach cancer	2.65e-05	0.000112	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1B—stomach cancer	2.64e-05	0.000112	CbGpPWpGaD
Orlistat—PNLIP—Disease—KRAS—stomach cancer	2.64e-05	0.000112	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—stomach cancer	2.62e-05	0.000111	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—stomach cancer	2.62e-05	0.000111	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ENO1—stomach cancer	2.61e-05	0.000111	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1B—stomach cancer	2.61e-05	0.000111	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	2.61e-05	0.000111	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—STAT3—stomach cancer	2.6e-05	0.00011	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—STAT3—stomach cancer	2.6e-05	0.00011	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.57e-05	0.000109	CbGpPWpGaD
Orlistat—FASN—Metabolism—NOS3—stomach cancer	2.55e-05	0.000108	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCND1—stomach cancer	2.49e-05	0.000106	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—JUN—stomach cancer	2.49e-05	0.000105	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAPK3—stomach cancer	2.48e-05	0.000105	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAPK3—stomach cancer	2.48e-05	0.000105	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1A—stomach cancer	2.44e-05	0.000103	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.43e-05	0.000103	CbGpPWpGaD
Orlistat—PNLIP—Disease—PIK3CA—stomach cancer	2.42e-05	0.000103	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—stomach cancer	2.42e-05	0.000102	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MYC—stomach cancer	2.41e-05	0.000102	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MYC—stomach cancer	2.41e-05	0.000102	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1A—stomach cancer	2.41e-05	0.000102	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.4e-05	0.000102	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAPK1—stomach cancer	2.36e-05	0.0001	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAPK1—stomach cancer	2.36e-05	0.0001	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EGFR—stomach cancer	2.36e-05	0.0001	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EGFR—stomach cancer	2.36e-05	0.0001	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK8—stomach cancer	2.35e-05	9.97e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—stomach cancer	2.33e-05	9.89e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CD44—stomach cancer	2.32e-05	9.82e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGTR2—stomach cancer	2.31e-05	9.77e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HSPB1—stomach cancer	2.31e-05	9.77e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—BMP2—stomach cancer	2.28e-05	9.66e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—F2R—stomach cancer	2.28e-05	9.66e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ACAD8—stomach cancer	2.28e-05	9.64e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.25e-05	9.53e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKR1C3—stomach cancer	2.24e-05	9.5e-05	CbGpPWpGaD
Orlistat—PNLIP—Disease—HRAS—stomach cancer	2.24e-05	9.5e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KRAS—stomach cancer	2.23e-05	9.44e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KRAS—stomach cancer	2.23e-05	9.44e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1A—stomach cancer	2.22e-05	9.4e-05	CbGpPWpGaD
Orlistat—FASN—Disease—STAT3—stomach cancer	2.17e-05	9.21e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—stomach cancer	2.17e-05	9.2e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—STAT3—stomach cancer	2.15e-05	9.11e-05	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—stomach cancer	2.15e-05	9.09e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ANXA1—stomach cancer	2.14e-05	9.08e-05	CbGpPWpGaD
Orlistat—FASN—Disease—MAPK3—stomach cancer	2.08e-05	8.8e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB1—stomach cancer	2.08e-05	8.79e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK3—stomach cancer	2.06e-05	8.71e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CA—stomach cancer	2.05e-05	8.68e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CA—stomach cancer	2.05e-05	8.68e-05	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CA—stomach cancer	2.03e-05	8.6e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GMPR2—stomach cancer	2.03e-05	8.59e-05	CbGpPWpGaD
Orlistat—FASN—Disease—MYC—stomach cancer	2.02e-05	8.56e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MYC—stomach cancer	2e-05	8.47e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RPS6—stomach cancer	1.98e-05	8.4e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—stomach cancer	1.98e-05	8.39e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—stomach cancer	1.98e-05	8.39e-05	CbGpPWpGaD
Orlistat—FASN—Disease—MAPK1—stomach cancer	1.98e-05	8.37e-05	CbGpPWpGaD
Orlistat—FASN—Disease—EGFR—stomach cancer	1.98e-05	8.37e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPP2R1A—stomach cancer	1.97e-05	8.35e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK1—stomach cancer	1.96e-05	8.28e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EGFR—stomach cancer	1.96e-05	8.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PRKCB—stomach cancer	1.95e-05	8.27e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—stomach cancer	1.95e-05	8.24e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6ST—stomach cancer	1.94e-05	8.23e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTP1—stomach cancer	1.93e-05	8.19e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HMOX1—stomach cancer	1.91e-05	8.08e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HRAS—stomach cancer	1.89e-05	8.03e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HRAS—stomach cancer	1.89e-05	8.03e-05	CbGpPWpGaD
Orlistat—FASN—Disease—KRAS—stomach cancer	1.87e-05	7.91e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—IDH3B—stomach cancer	1.86e-05	7.86e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.86e-05	7.86e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—KRAS—stomach cancer	1.85e-05	7.82e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MAPK3—stomach cancer	1.84e-05	7.8e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HBEGF—stomach cancer	1.82e-05	7.72e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—stomach cancer	1.81e-05	7.68e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—stomach cancer	1.81e-05	7.68e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TYMS—stomach cancer	1.8e-05	7.61e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTM1—stomach cancer	1.78e-05	7.53e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MAPK1—stomach cancer	1.75e-05	7.42e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6R—stomach cancer	1.73e-05	7.34e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.73e-05	7.31e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.73e-05	7.31e-05	CbGpPWpGaD
Orlistat—FASN—Disease—PIK3CA—stomach cancer	1.71e-05	7.26e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CA—stomach cancer	1.7e-05	7.19e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB2—stomach cancer	1.68e-05	7.12e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ERCC2—stomach cancer	1.67e-05	7.08e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—KRAS—stomach cancer	1.65e-05	7.01e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PPP2R1A—stomach cancer	1.65e-05	6.98e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—stomach cancer	1.64e-05	6.95e-05	CbGpPWpGaD
Orlistat—FASN—Disease—HRAS—stomach cancer	1.59e-05	6.72e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—stomach cancer	1.57e-05	6.65e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HRAS—stomach cancer	1.57e-05	6.65e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—RHOA—stomach cancer	1.57e-05	6.63e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—BLVRB—stomach cancer	1.54e-05	6.51e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PGLS—stomach cancer	1.54e-05	6.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SMAD4—stomach cancer	1.53e-05	6.48e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CA—stomach cancer	1.52e-05	6.44e-05	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—stomach cancer	1.52e-05	6.43e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—stomach cancer	1.5e-05	6.37e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—stomach cancer	1.47e-05	6.23e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.47e-05	6.21e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FYN—stomach cancer	1.45e-05	6.15e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CAV1—stomach cancer	1.45e-05	6.13e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOA1—stomach cancer	1.44e-05	6.12e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CA—stomach cancer	1.44e-05	6.08e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HRAS—stomach cancer	1.41e-05	5.96e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.38e-05	5.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—stomach cancer	1.37e-05	5.82e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGFR2—stomach cancer	1.36e-05	5.78e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.31e-05	5.54e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—FBP1—stomach cancer	1.31e-05	5.54e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CKB—stomach cancer	1.31e-05	5.54e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CA1—stomach cancer	1.31e-05	5.54e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—stomach cancer	1.27e-05	5.39e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IRS2—stomach cancer	1.25e-05	5.29e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLIN2—stomach cancer	1.23e-05	5.21e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CAV1—stomach cancer	1.21e-05	5.13e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOA1—stomach cancer	1.21e-05	5.12e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CA2—stomach cancer	1.2e-05	5.06e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PGAM1—stomach cancer	1.17e-05	4.94e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NT5E—stomach cancer	1.17e-05	4.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRKCB—stomach cancer	1.15e-05	4.88e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6ST—stomach cancer	1.15e-05	4.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—stomach cancer	1.14e-05	4.85e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.11e-05	4.71e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLCE1—stomach cancer	1.11e-05	4.71e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APC—stomach cancer	1.1e-05	4.67e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—stomach cancer	1.1e-05	4.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—UMPS—stomach cancer	1.07e-05	4.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MAPK3—stomach cancer	1.06e-05	4.47e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6R—stomach cancer	1.02e-05	4.34e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MAPK1—stomach cancer	1.01e-05	4.26e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EGFR—stomach cancer	1e-05	4.26e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—stomach cancer	1e-05	4.24e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PDHA1—stomach cancer	9.91e-06	4.2e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ECHS1—stomach cancer	9.91e-06	4.2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SERPINE1—stomach cancer	9.59e-06	4.06e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—KRAS—stomach cancer	9.49e-06	4.02e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—FADS1—stomach cancer	9.32e-06	3.95e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TYMP—stomach cancer	9.32e-06	3.95e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RHOA—stomach cancer	9.25e-06	3.92e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—stomach cancer	9.16e-06	3.88e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SREBF2—stomach cancer	8.72e-06	3.69e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CA—stomach cancer	8.72e-06	3.69e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—RORA—stomach cancer	8.62e-06	3.65e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ERBB2—stomach cancer	8.56e-06	3.63e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—stomach cancer	8.12e-06	3.44e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDOB—stomach cancer	8.08e-06	3.42e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HRAS—stomach cancer	8.07e-06	3.42e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1B—stomach cancer	7.93e-06	3.36e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—stomach cancer	7.72e-06	3.27e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCND1—stomach cancer	7.57e-06	3.21e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JUN—stomach cancer	7.55e-06	3.2e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALOX5—stomach cancer	7.51e-06	3.18e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DPYD—stomach cancer	7.39e-06	3.13e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—stomach cancer	7.35e-06	3.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1A—stomach cancer	7.32e-06	3.1e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK8—stomach cancer	7.14e-06	3.03e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—stomach cancer	6.6e-06	2.79e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTT1—stomach cancer	6.53e-06	2.77e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STAT3—stomach cancer	6.53e-06	2.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.46e-06	2.74e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.28e-06	2.66e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK3—stomach cancer	6.24e-06	2.64e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CA—stomach cancer	6.16e-06	2.61e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ENO1—stomach cancer	6.12e-06	2.59e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MYC—stomach cancer	6.07e-06	2.57e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK1—stomach cancer	5.94e-06	2.52e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EGFR—stomach cancer	5.94e-06	2.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KRAS—stomach cancer	5.61e-06	2.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CD44—stomach cancer	5.43e-06	2.3e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CA—stomach cancer	5.15e-06	2.18e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—stomach cancer	4.98e-06	2.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HRAS—stomach cancer	4.77e-06	2.02e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.62e-06	1.96e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—stomach cancer	4.56e-06	1.93e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTP1—stomach cancer	4.53e-06	1.92e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMOX1—stomach cancer	4.47e-06	1.89e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TYMS—stomach cancer	4.21e-06	1.78e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM1—stomach cancer	4.16e-06	1.76e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ERCC2—stomach cancer	3.91e-06	1.66e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—stomach cancer	3.68e-06	1.56e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CAV1—stomach cancer	3.39e-06	1.44e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA1—stomach cancer	3.38e-06	1.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—stomach cancer	2.98e-06	1.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—stomach cancer	2.68e-06	1.14e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—stomach cancer	2.56e-06	1.09e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—stomach cancer	2.35e-06	9.94e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.44e-06	6.11e-06	CbGpPWpGaD
